Pfizer to Cash In on Cardiovascular Treatments as Heart Attack Deaths Skyrocket
Pharmaceutical giant Pfizer is set to cash in on new cardiovascular treatments as heart failure cases and related deaths skyrocket around the world.
Arena Pharmaceuticals